Use of cffDNA to avoid administration of anti‐D to pregnant women when the fetus is RhD‐negative: implementation in the NHS

Publisher： John Wiley & Sons Inc

E-ISSN： 1471-0528|122|12|1682-1686

ISSN： 1470-0328

Source： BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol.122, Iss.12, 2015-11, pp. : 1682-1686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Large-Scale Pre-Diagnosis Study of Fetal RHD Genotyping by PCR on Plasma DNA from RhD-Negative Pregnant Women

By Sciellour C.R-L.  

Molecular Diagnosis, Vol. 8, Iss. 1, 2004-01 ,pp. : 23-31

Adis International

Access to resources Recommend Favorite

Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti‐D therapy in Australia: A cost‐effectiveness analysis

By  

PRENATAL DIAGNOSIS, Vol. 37, Iss. 12, 2017-12 ,pp. : 1245-1253

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti-D Antibodies in Pregnant D Variant Antigen Carriers Initially Typed as RhD+

By  

Transfusion Medicine and Hemotherapy, Vol. 43, Iss. 6, 2016-10 ,pp. : 419-424

Karger

Access to resources Recommend Favorite

Routine Postnatal Use of the Kleihauer-Betke Test for Anti-D Administration in Rhesus D–Incompatible Pregnancies: A Medical Student Quality Improvement Project

By Lilic Nikola   Jayanatha Kalpa   Stone Peter  

Joint Commission Journal on Quality and Patient Safety, Vol. 39, Iss. 7, 2013-07 ,pp. : 324-0

Joint Commission Resources

Access to resources Recommend Favorite

Inhibition of phagocytic recognition of anti‐D opsonized Rh D+ RBC by polymer‐mediated immunocamouflage

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 12, 2015-12 ,pp. : 1165-1170

John Wiley & Sons Inc

Access to resources Recommend Favorite